Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
The Evolving Story of Triglycerides and Coronary Heart Disease Risk
Ann Marie Navar
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses
Yi-Qian Sun et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Rufeng Dai et al.
BMC NEPHROLOGY (2019)
Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in US Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014
Wenjun Fan et al.
DIABETES CARE (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
Luca A. Lotta et al.
JAMA CARDIOLOGY (2018)
Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization
James R. Staley et al.
GENETIC EPIDEMIOLOGY (2017)
Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
Michael V. Holmes et al.
NATURE REVIEWS CARDIOLOGY (2017)
Angiopoietin-like 3 in lipoprotein metabolism
Sander Kersten
NATURE REVIEWS ENDOCRINOLOGY (2017)
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
Mark J. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
F. E. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies
Peter Wurtz et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
PhenoScanner: a database of human genotype-phenotype associations
James R. Staley et al.
BIOINFORMATICS (2016)
Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence
Qin Wang et al.
BMC MEDICINE (2016)
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Frederick F. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
George Davey Smith et al.
HUMAN MOLECULAR GENETICS (2014)
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
GD Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Share Paper
